drugset / Trial / NCT03298464
Study of NGM313 in Obese Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaulate the safety, tolerability, and efficacy of NGM313 in obese participants
Timeline
- Start
- 2017-09-11
- Primary completion
- 2018-06-19
- Completion
- 2018-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NGM313 | Unknown | — | Subcutaneous |
| Comparator | Pioglitazone | Small molecule | — | Oral |